Evidence map›Paper›PMID 41798751›Full record

ArticleFrontiers in cellular and infection microbiology2026

OmpK35/36 absence does not confer carbapenem-resistance alone nor ceftazidime-avibactam resistance with one

Susu Wu, Yinyin Yang, Wanyao Xiang, Jin Zhang, Xinhua Luo, Mengqiao Xu, Dakang Hu, Haifang Zhang

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Susu Wu *Department of Laboratory Medicine, Taizhou Municipal Hospital (Taizhou University Affiliated Municipal Hospital), School of Medicine, Taizhou University, Taizhou, Zhejiang, China.
Yinyin Yang *Endoscopy Center of Taizhou Hospital Affiliated to Wenzhou Medical University, Taizhou, Zhejiang, China.
Wanyao Xiang *Department of Laboratory Medicine, Taizhou Municipal Hospital (Taizhou University Affiliated Municipal Hospital), School of Medicine, Taizhou University, Taizhou, Zhejiang, China.
Jin ZhangDepartment of Laboratory Medicine, Taizhou Municipal Hospital (Taizhou University Affiliated Municipal Hospital), School of Medicine, Taizhou University, Taizhou, Zhejiang, China.
Xinhua LuoDepartment of Laboratory Medicine, Taizhou Municipal Hospital (Taizhou University Affiliated Municipal Hospital), School of Medicine, Taizhou University, Taizhou, Zhejiang, China.
Mengqiao XuDepartment of Laboratory Medicine, Taizhou Municipal Hospital (Taizhou University Affiliated Municipal Hospital), School of Medicine, Taizhou University, Taizhou, Zhejiang, China.
Dakang HuDepartment of Laboratory Medicine, Taizhou Municipal Hospital (Taizhou University Affiliated Municipal Hospital), School of Medicine, Taizhou University, Taizhou, Zhejiang, China.
Haifang ZhangDepartment of Clinical Laboratory, the Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Investigate the genetic background of porin OmpK35/36 in Methods: 1407 Results: The rates of Conclusions: Highly conserved

Indexed as

Anti-Bacterial AgentsAzabicyclo CompoundsBacterial Proteinsbeta-LactamasesCarbapenemsCeftazidimeDrug Resistance, Multiple, BacterialKlebsiella pneumoniaePorinsDrug CombinationsHumansKlebsiella InfectionsMicrobial Sensitivity TestsPhylogenyThird Generation CephalosporinsAnti-Bacterial Agentsavibactam, ceftazidime drug combinationAzabicyclo CompoundsBacterial Proteinsbeta-lactamase KPC-2, Klebsiella pneumoniaebeta-LactamasesCarbapenemsCeftazidimeDrug CombinationsOmpK35 porin, Klebsiella pneumoniaeOmpK36 protein, Klebsiella pneumoniaePorinsThird Generation Cephalosporinscarbapenemceftazidime-avibactamKlebsiella pneumoniaepolymorphismporin

Identifiers

PMID41798751
PMCPMC12963322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.